RAZOXANE AND METHOTREXATE RESISTANCE
- 1 January 1977
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 309 (8001), 47
- https://doi.org/10.1016/s0140-6736(77)91687-7
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- RAZOXANE (ICRF 159) IN PSORIASISThe Lancet, 1976
- LEVAMISOLE AND AGRANULOCYTOSISThe Lancet, 1976
- The value of adriamycin in overcoming resistance to methotrexate in tissue cultureEuropean Journal of Cancer (1965), 1976
- ICRF 159, (±) 1,2-di(3,5-dioxopiperazin-1-yl)propane NSC-129,943; RazoxaneCancer Treatment Reviews, 1976
- Adriamycin—A ReviewJNCI Journal of the National Cancer Institute, 1975
- The cell cycle and its significance for cancer treatmentCancer Treatment Reviews, 1975
- Methodichlorophen as anti-tumor drug.BMJ, 1975
- Studies Concerned with Overcoming Resistance to Methotrexate: A Comparison of the Effects of Methotrexate and 2,4-Diamino-5-(3′,4′-Dichlorophenyl)-6-Methylpyrimidine (BW50197) on the Colony Forming Ability of L5178Y CellsBritish Journal of Cancer, 1973
- The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y)Biochemical Pharmacology, 1968